Clinical Trials Browser

Phase NA × Withdrawn × camrelizumab × Clear all

NCT04420130 2022-10-04

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

Phase NA Withdrawn

Gastrointestinal

Pancreatic Neoplasms